Cardiovascular Risk Factors — Lifestyle Modifications | NEJM

Why It Matters

Translating large-scale evidence into practical, individualized lifestyle and treatment strategies can substantially reduce cardiovascular events and healthcare burden; equipping clinicians with concrete tools and adaptive tobacco pharmacotherapies improves the odds of durable risk-factor control.

Summary

A New England Journal of Medicine review of data from hundreds of thousands worldwide reconfirms that traditional risk factors—overweight/obesity, smoking, hypertension, dyslipidemia and diabetes—are the primary causal drivers of cardiovascular disease and that addressing them through lifestyle change is essential. Clinicians are urged to use structured frameworks such as the American Heart Association’s Life’s Essential 8 to combine behavior counseling with targeted risk-factor management. Practical, scalable interventions highlighted include promoting home-based Mediterranean-style eating and reduced processed-sodium intake, daily moderate physical activity tailored to patients’ abilities, SMART goals for incremental change, and individualized tobacco treatment combining pharmacotherapy and behavioral support. The piece emphasizes actionable clinician strategies for eliciting patients’ starting points and barriers and for consolidating small, sustainable successes.

Original Description

This second episode of a two-part Double Take miniseries on cardiovascular risk factors from the New England Journal of Medicine reviews lifestyle-modification strategies to support blood-pressure control, including strategies focused on diet, exercise, and smoking. It describes the challenges of smoking cessation and outlines interventions to help patients quit — another critical step in reducing cardiovascular disease.

For further reading, the following article, referenced in this video, is available at NEJM.org: Global Effect of Cardiovascular Risk Factors on Lifetime Estimates (The Global Cardiovascular Risk Consortium, in the July 10, 2025, issue, https://www.nejm.org/doi/full/10.1056/NEJMoa2415879 ).

Funding for this Double Take is provided by the Doris Duke Foundation, committed to building a creative, equitable, and sustainable future.

The New England Journal of Medicine is the world’s leading general medical journal. Continuously published for over 200 years, the Journal publishes peer-reviewed research along with interactive clinical content for physicians, educators, and the global medical community at NEJM.org.